乳腺癌筛查策略争议

　　2016年3月31日～4月2日，国家综合癌症网络（NCCN）第21届年会在佛罗里达好莱坞召开。2016年5月，《国家综合癌症网络杂志》增刊发表德克萨斯大学MD安德森癌症中心NCCN乳腺癌筛查和诊断指南委员会主任、加利福尼亚大学旧金山分校美国预防服务工作委员会主任、纽约纪念斯隆·凯特琳癌症中心美国癌症学会乳腺癌筛查指南委员会主任对乳腺癌筛查策略争议的概述。

J Natl Compr Canc Netw. 2016 May;14(5 Suppl):651-3.

Controversies in Breast Cancer Screening Strategies.

Bevers T, Bibbins-Domingo K, Oeffinger KC, Smith ML.

The University of Texas MD Anderson Cancer Center, Houston, Texas, Chair of the NCCN Guidelines for Breast Cancer Screening and Diagnosis; University of California, San Francisco, San Francisco, California, Chair of the U.S. Preventive Services Task Force; Memorial Sloan Kettering Cancer Center, New York, New York, Chair of the American Cancer Society Breast Cancer Screening Guideline Panel; Research Advocacy Network, Naperville, Illinois.

A panel discussion on controversies in breast cancer screening held recently at the NCCN 21st Annual Conference included only a few controversies. Representatives of the U.S. Preventive Services Task Force, American Cancer Society, and NCCN disagreed primarily on 2 main areas: when to start screening (ages 40, 45, or 50 years) and frequency of screening (annual vs biennial). Panelists from these organizations presented the rationales for their respective recommendations.

PMID: 27226505